CHA Vaccine Research Institute (KOSDAQ:261780)

KOSDAQ:261780 Revenue

In the year 2024, CHA Vaccine Research Institute had annual revenue of 370.66M KRW with 26.02% growth. CHA Vaccine Research Institute had revenue of -10.00 in the quarter ending December 31, 2024.

• Revenue: 370.66M
• Revenue Growth: +26.02%
• P/S Ratio: 212.76
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 78.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	370.66M	76.53M	26.02%
Dec 31, 2023	294.12M	114.64M	63.87%
Dec 31, 2022	179.48M	-320.52M	-64.10%
Dec 31, 2021	500.00M	422.20M	542.70%
Dec 31, 2020	77.80M	-48.32M	-38.31%